Literature DB >> 11729942

Response to repeated CO2 in individuals with elevated anxiety sensitivity: replication with 20% CO2.

J G Beck1, M S Wolf.   

Abstract

The present report replicates and extends previous work examining response patterns to repeated presentation of CO2. In previous studies, two distinct response patterns to repeated presentation of 35% CO2 were noted, representing habituation and nonhabituation of anxiety. In this report, 21 participants who had never experienced a panic attack but who reported high levels of anxiety sensitivity were presented with 12 trials of 20% CO2, followed by a trial involving inhalation of room air (to examine dishabituation) and two more trials of 20% CO2. Results indicated that 67% of the sample reported habituation of anxiety. Reductions in anxiety across inhalations were paralleled by changes in tidal volume, perceived panic symptom severity, and feelings of panic. Notable dishabituation was observed in the nonhabituation sample. Results are discussed in the light of basic learning processes underlying the treatment of Panic Disorder (PD).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11729942     DOI: 10.1016/s0005-7916(01)00018-0

Source DB:  PubMed          Journal:  J Behav Ther Exp Psychiatry        ISSN: 0005-7916


  3 in total

1.  Respiratory, autonomic, and experiential responses to repeated inhalations of 20% CO₂ enriched air in panic disorder, social phobia, and healthy controls.

Authors:  Jens Blechert; Frank H Wilhelm; Alicia E Meuret; Eva M Wilhelm; Walton T Roth
Journal:  Biol Psychol       Date:  2010-01-12       Impact factor: 3.251

Review 2.  Paroxysmal hypertension: the role of stress and psychological factors.

Authors:  Thomas G Pickering; Lynn Clemow
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-07       Impact factor: 3.738

3.  Examining the short-term anxiolytic and antidepressant effect of Floatation-REST.

Authors:  Justin S Feinstein; Sahib S Khalsa; Hung-Wen Yeh; Colleen Wohlrab; W Kyle Simmons; Murray B Stein; Martin P Paulus
Journal:  PLoS One       Date:  2018-02-02       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.